Becker's Healthcare December 2, 2024
Jakob Emerson

The prices for some GLP-1s have dropped significantly in recent years for individuals covered by Medicare and commercial insurance, according to a new report from HHS.

In 2024, the U.S. list prices for a one-month supply for most GLP-1s are stable or increasing, but after payer negotiations and rebates, net prices for many GLP-1s have decreased since 2022. Net prices for GLP-1s are between 24% and 73% lower than list prices, indicating that most insurers...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Insurance, Pharma / Biotech
Medicaid spending ranked by share of state budgets
Drug Price Negotiation Requires Oversight To Protect Older Americans
Medicare Advantage payments expected to rise in 2026, and doctors are dismayed
Scaling Medicaid Innovation with Afia Asamoah, Rajaie Batniji, and Sanjay Basu
Nevada receives federal approval for public insurance option

Share This Article